ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

OCUL Ocular Therapeutix Inc

6.32
0.45 (7.67%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Ocular Therapeutix Inc OCUL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.45 7.67% 6.32 17:08:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.06 6.03 6.395 6.17 5.87
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202406:30GLOBEOcular Therapeutix™ To Present at Two Ophthalmology..
01/5/202406:30GLOBEOcular Therapeutix™ to Host Investor Day in New York City on..
11/3/202415:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202415:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202415:10EDGAR2Form 8-K - Current report
11/3/202405:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
27/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202419:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/2/202419:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202407:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202406:34EDGAR2Form 8-K - Current report
19/2/202408:00PRNUSAffaMed Therapeutics Announces New Drug Application..
15/2/202407:00GLOBEOcular Therapeutix™ Appoints Steve Meyers to Chief..
14/2/202418:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202406:37GLOBEOcular Therapeutix™ Announces First Subjects Screened in..
06/2/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202415:41EDGAR2Form 144 - Report of proposed sale of securities
05/2/202415:39EDGAR2Form 144 - Report of proposed sale of securities
05/2/202415:36EDGAR2Form 144 - Report of proposed sale of securities
05/2/202415:33EDGAR2Form 144 - Report of proposed sale of securities
05/2/202415:30EDGAR2Form 144 - Report of proposed sale of securities
02/2/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202416:39EDGAR2Form 144 - Report of proposed sale of securities
31/1/202416:36EDGAR2Form 144 - Report of proposed sale of securities
31/1/202416:34EDGAR2Form 144 - Report of proposed sale of securities
31/1/202416:31EDGAR2Form 144 - Report of proposed sale of securities
25/1/202407:04EDGAR2Form 8-K - Current report
28/12/202315:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/12/202315:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202315:52EDGAR2Form SC 13D/A - General statement of acquisition of..
18/12/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:01GLOBEOcular Therapeutix™ Announces Closing of Public Offering of..
14/12/202315:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202307:46EDGAR2Form 8-K - Current report
13/12/202321:09GLOBEOcular Therapeutix™ Announces Pricing of Public Offering of..
13/12/202318:07DJNStocks to Watch: Adobe, Amtech Systems, Ocular Therapeutix
13/12/202315:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202315:01GLOBEOcular Therapeutix™ Announces Proposed Public Offering of..
16/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness

Su Consulta Reciente

Delayed Upgrade Clock